Sofosbuvir/Velpatasvir (SOF/VEL)-Based Regimens are Associated with Excellent Efficacy and a Significant Improvement of Patients-Reported Outcomes (PROs) across Patient Populations: From Non-Cirrhotics to Compensated Cirrhotics to Decompensated Cirrhotics

被引：0

作者：

Younossi, Zobair M. ^{[1
]}

Stepanova, Maria ^{[2
]}

Feld, Jordan J. ^{[3
]}

Zeuzem, Stefan ^{[4
]}

Sulkowski, Mark S. ^{[5
]}

Foster, Graham R. ^{[6
]}

Mangia, Alessandra ^{[7
]}

Charlton, Michael R. ^{[8
]}

O'Leary, Jacqueline G. ^{[9
]}

Curry, Michael P. ^{[10
]}

Nader, Fatema ^{[2
]}

Henry, Linda ^{[2
]}

Hunt, Sharon ^{[2
]}

机构：

[1] Inova Fairfax Hosp, Ctr Liver Dis, Dept Med, Falls Church, VA USA

[2] Ctr Outcomes Res Liver Dis, Washington, DC USA

[3] Toronto Ctr Liver Dis, Toronto, ON, Canada

[4] Goethe Univ Frankfurt, Med Ctr, Frankfurt, Germany

[5] Johns Hopkins Univ, Baltimore, MD USA

[6] Queen Mary Univ London, London, England

[7] Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, Italy

[8] Intermt Med Ctr, Salt Lake City, UT USA

[9] Baylor Univ, Med Ctr, Dallas, TX USA

[10] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：12A / 12A

页数：1